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A B S T R A C T
Nowadays bacterial resistance to known antibiotics is a serious health problem. In order to achieve more
eﬃcient treatment, lately there is an effort to ﬁnd new substances, such as certain biomaterials, that are
non-toxic to humans with antibiotic potential. Lignins and lignin-derived compounds have been pro-
posed to be good candidates for use in medicine and health maintenance. In this study, the antibacterial
activity of the lignin model polymer dehydrogenate polymer (DHP) in alginate hydrogel (Alg) was studied.
The obtained results show that DHP−Alg has strong antimicrobial activity against several bacterial strains
and bioﬁlms and does not have a toxic effect on human epithelial cells. These results strongly suggest
its application as a wound healing agent or as an adjunct substance for wound treatments.
© 2016 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
1. Introduction
Lignins, the second most abundant organic compound on the
Earth’s surface, provide mechanical support to plant tissues as well
as protection from physical/chemical stress and disease resis-
tance. In plants, lignin is produced by oxidative coupling of three
phenolic alcohols/acids (coniferyl, p-coumaryl and synapyl) catalysed
by the enzyme peroxidase [1]. The enzymatically synthesised lignin
model compound dehydrogenate polymer (DHP) from coniferyl
alcohol is the best lignin substitute used in various experiments [2].
Lignins and lignin-derived compounds have been proposed to be
good candidates for use in medicine and health maintenance [3,4].
The antibacterial properties of different kinds of lignin (organosolv,
sulphite, kraft) have already been reported [5,6].
The aim of this study was to observe the effects of DHP,
synthesised from coniferyl alcohol, on different bacterial strains and
bacterial bioﬁlms both cultured in laboratory conditions as well as
wild strains isolated from patients’ wounds. In addition, its wound
healing effect was tested in vivo on sterile wounds induced on rat
skin. DHP was applied in the form of a suspension as well as in a
gel-like structure obtained by mixing it with sodium alginate (Alg)
and adding calcium salt.
2. Materials and methods
2.1. Synthesis of dehydrogenate polymer and preparation of
suspension and gel
The DHP of coniferyl alcohol (Sigma-Aldrich, St. Louis, MO) was
synthesised according to the procedure described by Radotíc et al
[7,8]. The obtained polymer was air-dried and was dissolved in di-
methyl sulphoxide (DMSO).
Sodium alginate (Sigma) (0.2 g) was dissolved in 9.5 mL of dis-
tilled water. Subsequently, 0.5mL of DHP in DMSOwas added, giving
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a ﬁnal concentration of 1% (w/v) DHP. Solutions were mixed, giving
a milky suspension. This suspension was further diluted to obtain
different concentrations. CaCl2 at a ﬁnal concentration of 0.5% (w/
v) was added to make the gel form.
2.2. Micro-organisms
The Gram-negative bacteria Enterobacter cloacae human isolate,
Escherichia coli ATCC 35210, Pseudomonas aeruginosa ATCC 27853
and Salmonella enterica serovar Typhimurium ATCC 13311 as well
as the Gram-positive bacteria Bacillus cereus clinical isolate, Liste-
ria monocytogenes NCTC 7973, Micrococcus ﬂavus ATCC 10240 and
Staphylococcus aureus ATCC 6538 were used. The organisms were
obtained from theMycological Laboratory, Department of Plant Phys-
iology, Institute for Biological Research ‘Siniša Stankovic´’, University
of Belgrade (Belgrade, Serbia). Another ﬁve isolates, including three
S. aureus (S.a. #1, S.a. #2 and S.a. #3), P. aeruginosa P.a. #1 and Ser-
ratia sp., were human isolates obtained from patients at the
Department of Microbiology, Clinical Center of Serbia (Belgrade,
Serbia). Bacteria were cultured on Mueller–Hinton agar (Merck,
Darmstadt, Germany) at 37 °C for 24 h.
2.3. Antibacterial activity
The dose dependence of DHP was determined (Supplementary
Table S1) and the stock suspension containing 10 mg/mL DHP and
20 mg/mL Alg was used for bacterial treatments. The minimum in-
hibitory concentration (MIC) and minimum bactericidal
concentration (MBC) were determined by the microdilution method
[9,10]. The compound for testing was added in tryptic soy broth
medium (100 μL) with bacterial inoculum (1.0 × 105 CFU/well) to
achieve the required concentration plus Ca2+ to a ﬁnal concentra-
tion of 0.5%. Antibacterial activity was determined in regard to the
DHP concentration (mg/mL) in the microplate wells. Microplates
were incubated in a rotary shaker (160 rpm) for 24 h at 37 °C. MICs
obtained from the susceptibility testing of various bacteria to the
tested compound DHP−Alg were also determined by a colorimet-
ric microbial viability assay based on reduction of 2-(4-iodophenyl)-
3-(4-nitrophenyl)-5-phenyl-2H-tetrazolium (INT) colour and
compared with the positive control for each bacterial strain [9,10].
The lowest concentration with no visible growth (at the binocular
microscope) was deﬁned as the concentration that completely in-
hibited bacterial growth (the MIC). MBCs were determined by serial
subcultivation of 2 μL into microtitre plates containing 100 μL of
broth per well and further incubation for 24 h. The lowest concen-
tration with no visible growth was deﬁned as the MBC, indicating
99.5% killing of the original inoculum. The optical density at 655 nm
of each well was measured using Microplate Manager® 4.0 (Bio-
Rad Laboratories, Hercules, CA) and was compared with a blank and
the positive control. The antibiotics streptomycin (Sigma) and am-
picillin (Panfarma, Belgrade, Serbia) were used as positive controls
(1 mg/mL in sterile physiological saline).
2.4. Quantiﬁcation of bioﬁlm formation and effect of DHP–Alg on
established bioﬁlms
Five clinical isolates (three S. aureus, P. aeruginosa and Serratia
sp.) were chosen for bioﬁlm investigation experiments. Each isolate
was characterised for bioﬁlm-related properties as reported pre-
viously [11,12].
Bioﬁlm biomass was quantiﬁed using amodiﬁcation of a method-
ology described by Stepanovíc et al [13]. Brieﬂy, 200 μL of an overnight
bacterial suspension containing 1 ×108 CFU/mLwas added to thewells
of a sterile 96-well ﬂat-bottomedmicrotitre plate (Sarstedt, Nümbrecht,
Germany). Negative controlswere represented bywells containing only
200 μL of the medium. S. aureus ATCC 25923 and P. aeruginosa ATCC
27853, known to form fully established bioﬁlms, were added to each
plate as a reference standard [14] and positive control, respectively. In-
cubationwas performed at 37 °C for 24 h. Subsequently, the liquidwas
aspirated, the wells were washed and sessile cells were stained with
crystal violet [15]. The absorbance was read at 620 nm [16]. The fol-
lowing classiﬁcationwas used: bioﬁlmnon-former (Doa ≤Docn);weak
bioﬁlm-former (Docn < Doa ≤ 2 × Docn); moderate bioﬁlm-former
(2×Docn<Doa≤4×Docn); and strong bioﬁlm-former (4×Docn<Doa);
where Doa is the optical density of the bioﬁlm and Docn is the optical
density of the negative growth control. To evaluate the susceptibility
of the bacterial bioﬁlms toDHP–Alg, 200μL of bacterial suspensionwas
added to a ﬂat-bottomed 96-well polystyrenemicroplate and was in-
cubated at 37 °C for 48 h to allow bioﬁlm formation. Afterwashing the
plates, DHP−Alg solution (200 μL) was added to the wells at concen-
trations ranging from0.08 to9mg/mL.Ampicillin and streptomycinwere
used as positive controls. After 24 h at 37 °C, bioﬁlm reductionwas de-
termined by following the staining process [10] and measuring
ultraviolet absorbance at 620nm. TheMICwasdeﬁned as theminimum
concentration of antimicrobial agent that inhibited further growth of
the initial bioﬁlm, and theMBCwas deﬁned as the concentration that
resulted in a level of luminescence representing no bacterial growth
(empty well).
2.5. Cytotoxicity testing
The cytotoxicity of DHP−Alg was assessed on human cervix car-
cinoma cells (Hep2c) and human conjunctival epithelial cells (HCjE)
(kindly provided by Prof. Ilene Gipson, Schepens Eye Research In-
stitute, Harvard Medical School, Boston, MA). Cells were seeded at
a density of 20,000 cells/well (100 μL/well) in 96-well ﬂat-bottomed
tissue culture plates (Nunc, Roskilde, Denmark) and were incu-
bated for 24 h with DHP−Alg at 37 °C in 5% CO2. A stock solution
of 10 mg/mL DHP−Alg in 5% DMSO was used for preparation of the
starting solutions, each containing 200 μg/mL DHP−Alg ﬁltered
through 0.22-μm pore-size ﬁlters and further used for the prepa-
ration of double serial dilution samples. Upon addition of DHP−Alg-
containing solutions (100 μL/well) to cell cultures, cells were
incubated for an additional 48 h at 37 °C in 5% CO2. Cells grown in
the appropriate medium only were used as a reference. Prelimi-
nary experiments showed that DMSO at the concentration range
used in experiment (<0.05%) had no impact on Hep2c and HCjE cell
viability.
Viability of the Hep2c and HCjE cells was determined using a
standard Cell Counting Kit-8 (a solution of WST-8 [2-(2-methoxy-
4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulphophenyl)-2H-
tetrazolium, monosodium salt]) (Sigma). The rate of WST-8
transformation positively correlates with cell viability. Brieﬂy, 10 μL/
well of Cell Counting Kit-8 solution was added into the wells and
4 h later the absorbance was measured at 450/650 nm.
2.6. In vivo test of DHP–Alg on wounds and histological/stereological
analysis
The methodology of the in vivo studies and the related histo-
logical analyses are presented in the Supplementary material.
2.7. Statistical analysis
In the antimicrobial activity tests, two samples for each species
were used and all of the assays were carried out in duplicate. The
results were analysed using one-way analysis of variance (ANOVA)
followed by Tukey’s HSD Test with α = 0.05 and were expressed as
the mean and standard error. This analysis was carried out using
IBM SPSS Statistics for Windows v.22.0 (IBM Corp., Armonk, NY).
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In the cytotoxicity tests, measurements were done in triplicate and
the mean values and standard deviation were determined.
3. Results
Compound DHP−Alg showed activity against all of the tested bac-
teria with MICs of 0.002–0.90 mg/mL and MBCs of 0.004–1.25 mg/
mL. L. monocytogenes was the most susceptible and S. aureus #3 was
the most resistant to DHP−Alg. DHP−Alg showed higher activity
against L. monocytogenes, P. aeruginosa and S. Typhimurium than the
antibiotics streptomycin and ampicillin. The results against S. aureus
#2 were similar to those shown by streptomycin and ampicillin
(Table 1).
The lignin model compound alone showed antimicrobial activ-
ity (Supplementary Tables S1 and S2), although its effect was weaker
in comparison with DHP−Alg.
All used clinical bacterial strains were capable of forming bioﬁlm
on polystyrenemicroplates. P. aeruginosa#1was classiﬁed as a strong
bioﬁlm former and the other strains were considered as moderate
bioﬁlm formers. All of the strains exhibited equal susceptibility to
DHP−Alg, with MICs and MBC of 4.50 mg/mL and 9.00 mg/mL, re-
spectively. The results for antibioﬁlm activity can be presented as
follows: streptomycin < DHP−Alg = ampicillin (Table 1).
DHP−Alg in the concentration range of 0.5–100 μg/mL did not
exert cytotoxic effects either in Hep2c or HCjE cells. The viability
of DHP−Alg-treated Hep2c cells was similarly enhanced com-
pared with control cells. Hep2c cell viability was enhanced upon
DHP−Alg stimulation (Fig. 1). The WST-8 transformation rate re-
vealed that for the tested DHP−Alg concentration range, the viability
of Hep2c cells was >90% and the viability of DHP−Alg-treated HCjE
cells was ≥100% (Supplementary Fig. S1). A possible explanation for
the enhanced WST-8 transformation rate of HCjE cells upon stim-
ulation with DHP−Alg could be the increase in metabolic activity
of HCjE and/or some mitogenic activity.
Since we found that DHP−Alg has a strong antimicrobial effect
against bacterial strains active in chronic wounds, but does not have
a toxic effect on human epithelial cells, we tested its effect on sterile
wounds made on rat skin by incision. The results are presented in
the Supplementary material and showed that DHP−Alg did not
induce any damaging effect on the wounds or on the surrounding
skin.
4. Discussion
These results show that DHP−Alg was active against all tested
Gram-positive and Gram-negative bacterial strains, with the stron-
gest activity on L. monocytogenes, P. aeruginosa, S. Typhimurium and
S. aureus. The effect against bacterial bioﬁlms was in the same range
Table 1
Antibacterial and antibioﬁlm activities of dehydrogenate polymer in alginate hydrogel (DHP–Alg) (mg/mL DHP).
Bacteria MIC/MBC (mg/mL)
DHP−Alg Streptomycin Ampicillin
Antibacterial activity
Bacillus cereus 0.23 ± 0.00a/0.45 ± 0.00e 0.05 ± 0.003a/0.1 ± 0.00a 0.10 ± 0.02b/0.15 ± 0.01b
Micrococcus ﬂavus 0.45 ± 0.01d/0.90 ± 0.01f 0.13 ± 0.01a/0.25 ± 0.01c 0.10 ± 0.00a/0.15 ± 0.01a
Staphylococcus aureus ATCC 6538 0.45 ± 0.02d/0.90 ± 0.006b 0.25 ± 0.00a/0.50 ± 0.07c 0.10 ± 0.02b/0.15 ± ± 0.01a
S. aureus #1* 0.11 ± 0.00b/0.45 ± 0.02d 0.05 ± 0.003a/0.1 ± 0.00a 0.50 ± 0.003b0.50 ± 0.09c
S. aureus #2* 0.11 ± 0.00b/0.45 ± 0.01d 0.13 ± 0.003a/0.25 ± 0.00a 0.13 ± 0.003a/0.25 ± 0.00a
S. aureus #3* 0.90 ± 0.02e/1.25 ± 0.03g 0.02 ± 0.007a/0.03 ± ± 0.00a 0.02 ± 0.00a/0.03 ± 0.02b
Listeria monocytogenes 0.002 ± 0.00a/0.004 ± 0.00a 0.15 ± 0.007a/0.30 ± 0.00a 0.15 ± 0.007b/0.30 ± 0.01a
Escherichia coli 0.70 ± 0.02a/0.90 ± 0.01f 0.10 ± 0.01a/0.50 ± 0.01a 0.30 ± 0.01a/0.50 ± 0.02a
Pseudomonas aeruginosa ATCC 27853 0.02 ± 0.00a/0.03 ± 0.00a,b 0.05 ± 0.01a/0.10 ± 0.01a 0.10 ± 0.03b/0.20 ± 0.09c
P. aeruginosa #1* 0.03 ± 0.00a/0.45 ± 0.01de 0.15 ± 0.007a0.03 ± 0.00a 0.0150.007a/0.03 ± 0.00a
Enterobacter cloacae 0.13 ± 0.002b/0.25 ± 0.01c 0.05 ± 0.02a/0.10 ± 0.00a 0.15 ± 0.01a/0.20 ± 0.02a
Salmonella Typhimurium 0.03 ± 0.00a/0.06 ± 0.00b 0.05 ± 0.007a/0.10 ± 0.007a 0.15 ± 0.00b/0.20 ± 0.01a
Serratia sp.* 0.02 ± 0.001a/0.03 ± 0.003a,b 0.015 ± 0.007a/0.015 ± 0.00a 0.02 ± 0.007a/0.02 ± 0.00a
Antibioﬁlm activity
S. aureus #1* 4.50 ± 0.08a/9.00 ± 0.00a 2.50 ± 0.04a/4.00 ± 0.12a 8.00 ± 0.09e/9.00 ± 0.08e
S. aureus #2* 4.50 ± 0.10a/9.00 ± 0.13a,b 5.00 ± 0.09e/6.00 ± 0.00d 8.00 ± 0.14e/9.00 ± 0.22e
S. aureus #3* 4.50 ± 0.08a/9.00 ± 0.09a,b 4.50 ± 0.07d/5.50 ± 0.07c 8.00 ± 0.00e/9.00 ± 0.10e
S. aureus ATCC 6538 4.50 ± 0.10a/9.00 ± 0.12a 2.50 ± 0.14f/3.50 ± 0.13e 2.00 ± 0.14b/3.00 ± 0.00b
P. aeruginosa #1* 4.50 ± 0.07a/9.00 ± 0.05a,b 6.50 ± 0.08b/7.50 ± 0.09a 7.50 ± 0.08d/8.50 ± 0.00d
P. aeruginosa ATCC 27853 4.50 ± 0.03a/9.00 ± 0.10a,b 3.00 ± 0.00b/4.00 ± 0.09a,b 1.50 ± 0.05a/2.50 ± 0.14a
Serratia sp.* 4.50 ± 0.23a/9.00 ± 0.09a,b 3.50 ± 0.06c/4.50 ± 0.09b 5.00 ± 0.08c/6.00 ± 0.1c
MIC, minimum inhibitory concentration; MBC, minimum bactericidal concentration.
* Clinical isolates.
In each column, and for MIC or MBC values, different letters mean signiﬁcant differences between samples (P < 0.05).
Fig. 1. Viability of Hep2c and HCjE cells measured with respect to the WST-8 trans-
formation rate. The ability of DHP−Alg-treated Hep2c and HCjE cells to transform
WST-8 into yellow-coloured products was evaluated by measuring the absorbance
at 450/650 nm (A450/650). Themean A450/650 was used for calculation of viability, taking
A450/650 calculated for cells grown at optimal conditions as 100%. DHP−Alg, dehy-
drogenate polymer in alginate hydrogel.
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as the antibiotics streptomycin and ampicillin. Dong et al [17] showed
that lignin extracts exhibited antimicrobial activities against some
Gram-positive, but not Gram-negative, bacteria with MIC and MBC
values in the range of the values obtained by DHP−Alg applied on
bacterial bioﬁlms and two or three orders of magnitude higher than
those obtained by DHP−Alg on laboratory strains. On the other hand,
DHP−Alg showed no cytotoxic effect on human Hep2c and HCjE
cells.
It is known that alginate itself does not have bactericidal activ-
ity, but it has the ability to immobilise and retain bacteria within
its ﬁbrous matrix [18,19], enabling reaction of active substance with
bacteria. Regarding the mechanism of antibacterial action, since
DHP−Alg did not have a toxic effect on human epithelial cells, it may
be speculated that DHP–Alg interacts with bacterial cell wall syn-
thesis and/or structure causing disorganisation of the cell wall and
consequently loss of functionality. For example, the mechanism of
glycopeptide and lipopeptide antibiotics is based on inhibition of
cell wall synthesis [20]. Our further studies are about to show the
mechanism of DHP−Alg toxicity on micro-organisms.
The activity of DHP–Alg against wild bacterial strains isolated
from patients with chronic wounds strongly suggests its applica-
tion as a wound healing agent or as an adjunct substance for wound
treatments. The results also show that DHP−Alg may be applied
either in the form of a suspension or gel, depending on the type of
treatment.
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